+49 (0)9103 729 1078 hello@quint.healthcare

Investor Relations

Our expertise helps investors assess their opportunities and risks.

h

Medical & Scientific Briefings

Comprehensive briefings on the medical and scientific background of investment cases

U

Due diligence

Medical and scientific due diligence

Z

Feasibility

Based on our experience in biomedical research, we can tell you what’s possible today, tomorrow or never.

Z

Compliance

We make sure investment cases follow current best practices and national / international guidelines

Methods in which we have first-hand experience

R

qPCR / PCR / RT-PCR

Nucleic acids and gene expression

R

Electrophoresis and Blotting

Polyacrylamide and agarose gel electrophoresis

R

Flow cytometry

Cell cycle analysis, viability, apoptosis, ploidy, kinetics, extracellular and intracellular protein expression, multidrug resistance, etc.

R

Microscopy

Live and time-lapse microscopy incl. functional (immuno-) fluorescence assays

R

Cell culture

Primary and established cell lines, monolayer-, co-culture and 3D spheroids

R

Flow cytometry

Western Blot (detection with AP & ECL), immunohistochemistry, protein microarrays, chromatin immunoprecipitation (ChIP)

R

Cell sorting

Fluorescence activated cell sorting (FACS)

R

Animal models

Genetically engineered animal tumor models, orthotopic tumor models, xenografts, etc.

R

Viability assays

Trypan blue, MTT, impedance based methods (e.g. xCELLigence by Roche)

R

Nucleic acid and protein isolation

From whole cells or cellular compartments, or through micro-dissection

R

Gene knock-down & overexpression

siRNA, shRNA, plasmid DNA vectors

We are motivated, visionary experts. How can we help you?